Toronto, July 26, 2016
Winterlight Labs’ technology that analyzes a person’s natural speech to detect and monitor Alzheimer’s disease and other cognitive disorders has won the AGE-WELL Pitch Competition: Technology to Support People with Dementia. Ten teams from Canada and around the world competed in the AGE-WELL Pitch Competition, which showcased a wide variety of technology solutions that address the many challenges faced by people living with dementia.
For more information, see the original release from AGE-WELL:
Canadian Technology that Uses Speech to Track Alzheimer’s Captures First Prize at AGE-WELL Pitch Competition
Winterlight Labs is commercializing a proprietary language-based diagnostic system that analyzes natural speech to detect and monitor dementia, Alzheimer’s, aphasia, and various other cognitive conditions. Winterlight's scalable platform uses short recorded speech samples to analyze hundreds of linguistic cues, and can detect dementia and other conditions with a high level of accuracy. This is a major improvement over current pencil-and-paper tests which are time-consuming, costly, and difficult to administer. The platform has applications in drug trials, long-term and primary care, and speech-language pathology.
Since its founding, Winterlight Labs has seen strong interest from pharmaceutical companies and other potential partners who view the technology as a major improvement over current methods of detection or screening. The company has gained support from the pan-Canadian AGE-WELL Network of Centres of Excellence (NCE), the Ontario Brain Institute, Ontario Centres of Excellence, and the University of Toronto Banting and Best Centre for Innovation and Entrepreneurship. For more information, visit www.winterlightlabs.com.
Liam Kaufman, CEO
liam [at] winterlightlabs.com